ThesisDue.comRequest examination

CAEM-B2B · proprietary diagnostic methodology

We test whether a venture deserves capital.We are built to say no.

Verdict

NO

Non-ergodic case

Examiner: G. Menshikov
109 items · evidence attached

ThesisDue is a diagnostic platform for B2B ventures and the people who fund them. We do not generate business plans. We measure the one thing a B2B venture lives or dies on — measurable change in customer behavior — and return a verdict with the evidence behind it.

Request an examinationRead the method
109
diagnostic questions
25 yrs
industrial B2B practice
3-way
verdict: invest / follow up / pass
0
guaranteed positive answers

01 — Methodology

Instruments of the examination

One premise: a B2B venture lives or dies on measurable change in customer behavior, not on projected revenue curves. This is what we actually measure.

KcuKcu coefficientDirect measurement of customer behavior change — the single number a B2B round is built or killed on.Behavioral
CA-ROICA-ROIReturn on customer-acquisition behavior, separating durable adoption from discount-driven churn.Economics
DBEPDynamic BEPBreak-even recomputed as a moving target on real unit economics, not the flat curve a deck assumes.Economics
BLKBlackout experimentsControlled demand-removal tests that verify causality before capital is committed.Evidence
ERGErgodicity splitErgodic markets, where mistakes are recoverable, versus non-ergodic ones, where a single error is terminal.Risk

Where a market is non-ergodic, a single error is terminal — and standard SaaS metrics simply do not apply. The classification comes first; the metrics come second.

02 — The verdict

A diagnostic that cannot say no is not a diagnostic

Most AI tools in this category are generators. Feed them three sentences and they return a polished document and a positive answer. Every examination here resolves to exactly one of three states.

State AInvestBehavioral evidence clears the committee threshold. Proceed — with the reasoning attached.
State BFollow upPromising but under-evidenced. Defined conditions and a date to re-test.
State CPassThe evidence does not support capital. The report explains why, point by point.

03 — Offerings

Five ways to put a venture under examination

01

Diagnostic

A structured examination of the venture built on 109 questions covering market, customer behavior, unit economics and evidence quality — assessed the way an investment committee assesses it, not the way a pitch deck presents it.

02

Verdict

A three-way outcome — invest, follow up, or pass — with the reasoning and the evidence behind it. No exceptions, no softening.

03

Agent skills

The methodology packaged as machine-readable skills and prompt chains, so an AI agent inside your own workflow runs the same diagnostic with a defined scope, approved sources of truth and escalation rules.

04

Knowledge base & books

AI-native reference material that is modular, structured and ready for retrieval. Written to be loaded into an agent as context, not read cover to cover.

05

Advisory

Direct work with the author on specific deals, portfolios and corporate innovation pipelines.

What makes us different

Diagnostic instead of generation. Behavioral evidence instead of financial fiction. Academic rigor combined with operator experience in real industrial B2B markets — and a product designed from the start for teams where humans and AI agents work side by side.

04 — Audience

Who requests an examination

  • i.FoundersPreparing a B2B round who need an honest verdict before an investor delivers one.
  • ii.Deal-flow teamsVenture capital, angel and corporate development teams screening deal flow.
  • iii.Corporate innovation unitsInnovation and strategy units testing internal ventures and partnerships.
  • iv.Accelerators & programsAccelerators and university entrepreneurship programs grading their cohorts.
GMThe examiner

05 — The author

Grigorii Menshikov

Author of CAEM-B2B

The methodology was developed over 25 years of industrial B2B practice and academic research — by someone who has sat on both sides of the examination: the operator who closed the deals, and the committee that decided whether they deserved to.

Credentials

  • PhD in Economics — MISiS
  • I-EMBA — Stockholm School of Economics
  • Founder — Synthmart LLC, Boston, Massachusetts

— signed, G. Menshikov

The request

Request an examination

This is a paid diagnostic, not a trial. Bring the venture. Receive a verdict — including a no.

Begin the examination

By application · Reviewed by the author